Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results

Patient Education and Counseling

Volumn 93, Issue 3, 2013, Pages 413-419

  Patrick Miller, Linda ^a   Egleston, Brian L ^b   Daly, Mary ^b   Stevens, Evelyn ^b   Fetzer, Dominique ^c   Forman, Andrea ^b   Bealin, Lisa ^b   Rybak, Christina ^b   Peterson, Candace ^b   Corbman, Melanie ^b   Bradbury, Angela R ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cancer risk assessment; Cancer susceptibility; Communication; Genetic testing

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AFRICAN AMERICAN; ANXIETY; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DEPRESSION; EDUCATIONAL STATUS; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GENETIC COUNSELOR; GENETIC SCREENING; HUMAN; INTERPERSONAL COMMUNICATION; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; OCCUPATION; PATIENT PARTICIPATION; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TELEPHONE; AGED; BREAST NEOPLASMS; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PROCEDURES; PROGRAM EVALUATION; PSYCHOLOGY; RISK ASSESSMENT; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

ADULT; AGED; ANXIETY; BREAST NEOPLASMS; COMMUNICATION; DEPRESSION; DISCLOSURE; FEASIBILITY STUDIES; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; PROGRAM EVALUATION; PROSPECTIVE STUDIES; RISK ASSESSMENT; TELEPHONE;

EID: 84888382573     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2013.08.009     Document Type: Article

References (49)

1. Khoury M.J., Gwinn M., Yoon P.W., et al. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?. Genet Med 2007, 9:665-674.
2. Burke W., Psaty B.M. Personalized medicine in the era of genomics. J Amer Med Assoc 2007, 298:1682-1684.
3. Robson M.E., Storm C.D., Weitzel J. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 2010, 28:893-901.
4. Schwartz G.F., Hughes K.S., Lynch H.T., et al. Proceedings of the international consensus conference on breast cancer risk, genetics, and risk management, April, 2007. Cancer 2008, 113:2627-2637.
5. Biesecker B.B., Boehnke M., Calzone K., et al. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. J Amer Med Assoc 1993, 269:1970-1974.
6. Jenkins J., Calzone K.A., Dimond E., et al. Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling. Genet Med 2007, 9:487-495.
7. Scheuner M.T., Sieverding P., Shekelle P.G. Delivery of genomic medicine for common chronic adult diseases: a systematic review. J Amer Med Assoc 2008, 299:1320-1334.
8. Helmes A.W., Culver J.O., Bowen D.J. Results of a randomized study of telephone versus in-person breast cancer risk counseling. Patient Educ Couns 2006, 64:96-103.
9. Peshkin B.N., Demarco T.A., Graves K.D., et al. Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial. Genet Test 2008.
10. McBride C.M., Rimer B.K. Using the telephone to improve health behavior and health service delivery. Patient Educ Couns 1999, 37:3-18.
11. Wang V.O. Commentary: what is and is not telephone counseling?. J Genet Couns 2000, 9:73-82.
12. Ormond K.E., Haun J., Cook L., et al. Recommendations for telephone counseling. J Genet Couns 2000, 9:63-71.
13. Campbell L., Watkins R.M., Teasdale C. Communicating the result of breast biopsy by telephone or in person. Br J Surg 1997, 84:1381.
14. Bradbury A.R., Patrick-Miller L., Fetzer D., et al. Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results. Clin Genet 2011, 79:125-131.
15. Chen W.Y., Garber J.E., Higham S., et al. BRCA1/2 genetic testing in the community setting. J Clin Oncol 2002, 20:4485-4492.
16. Doughty Rice C., Ruschman J.G., Martin L.J., et al. Retrospective comparison of patient outcomes after in-person and telephone results disclosure counseling for BRCA1/2 genetic testing. Fam Cancer 2010, 9:203-212.
17. Baumanis L., Evans J.P., Callanan N., et al. Telephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfaction. J Genet Couns 2009.
18. Christensen K.D., Roberts J.S., Shalowitz D.I., et al. Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers. Cancer Epidemiol Biomarkers Prev 2011, 20:522-529.
19. Weitzel J.N., Blazer K.R., Macdonald D.J., et al. Genetics, genomics, and cancer risk assessment: state of the art and future directions in the era of personalized medicine. CA Cancer J Clin 2011.
20. Patrick-Miller L., Bradbury A.R., Terry M.B. Controversies in communication of genetic screening results for cancer: a report from the American Society of Preventive Oncology's Screening Special Interest Group (ASPO's 33rd Annual Meeting, March 8 to 10, 2009, Tampa, Florida). Cancer Epidemiol Biomarkers Prev 2010, 19:624-627.
21. Bradbury A.R., Patrick-Miller L., Fetzer D., et al. Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results. Clin Genet 2011, 79:125-131.
22. Figg W.D., Smith E.K., Price D.K., et al. Disclosing a diagnosis of cancer: where and how does it occur?. J Clin Oncol 2013, 28:3630-3635.
23. Klemp J.R., O'Dea A., Chamberlain C., et al. Patient satisfaction of BRCA1/2 genetic testing by women at high risk for breast cancer participating in a prevention trial. Fam Cancer 2005, 4:279-284.
24. Hamilton J.G., Lobel M., Moyer A. Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychol 2009, 28:510-518.
25. O'Neill S.C., Rini C., Goldsmith R.E., et al. Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes. Psychooncology 2009, 18:1088-1096.
26. Leventhal H., Benyamini Y., Brownlee S., et al. Perceptions of health and illness: current research and applications. Illness representations: theoretical foundations 1997, 19-46. Harwood, Amsterdam. K.J. Petrie, J.A. Weinman (Eds.).
27. Kelly K., Leventhal H., Andrykowski M., et al. Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations. Psychooncology 2005, 14:34-48.
28. Riley B.D., Culver J.O., Skrzynia C., et al. Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. J Genet Couns 2012, 21:151-161.
29. Shiloh S. Illness representations, self-regulation, and genetic counseling: a theoretical review. J Genet Couns 2006, 15:325-337.
30. Shiloh S., Drori E., Orr-Urtreger A., et al. Being 'at-risk' for developing cancer: cognitive representations and psychological outcomes. J Behav Med 2009, 32:197-208.
31. Kelly K., Leventhal H., Marvin M., et al. Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations. Cancer Control 2004, 11:236-244.
32. Lerman C., Narod S., Schulman K., et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. J Amer Med Assoc 1996, 275:1885-1892.
33. Speilberger C.D., Gorsuch R.L., Lushene R., et al. Manual for the State-Trait Anxiety Inventory 1983, Consulting Psychologists Press, Palo Alto, CA.
34. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
35. Pieterse A.H., van Dulmen A.M., Beemer F.A., et al. Cancer genetic counseling: communication and counselees' post-visit satisfaction, cognitions, anxiety, and needs fulfillment. J Genet Couns 2007, 16:85-96.
36. Cella D., Hughes C., Peterman A., et al. A brief assessment of concerns associated with genetic testing for cancer: the multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol 2002, 21:564-572.
37. Bjelland I., Dahl A.A., Haug T.T., et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002, 52:69-77.
38. Stitzenberg K.B., Wong Y.N., Nielsen M.E., et al. Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care. Cancer 2012, 118:54-62.
39. Roussi P., Sherman K.A., Miller S., et al. Enhanced counselling for women undergoing BRCA1/2 testing: impact on knowledge and psychological distress-results from a randomised clinical trial. Psychol Health 2010, 25:401-415.
40. Dekker N., van Dorst E.B., van der Luijt R.B., et al. Acceptance of genetic counseling and testing in a hospital-based series of patients with gynecological cancer. J Genet Couns 2013, 22:345-357.
41. Halbert C.H., Kessler L.J., Mitchell E. Genetic testing for inherited breast cancer risk in African Americans. Cancer Invest 2005, 23:285-295.
42. Lynch H.T., Snyder C., Lynch J.F., et al. Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. Cancer Genet Cytogenet 2006, 165:91-97.
43. Kinney A.Y., Bloor L.E., Mandal D., et al. The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation. Cancer 2005, 104:2508-2516.
44. Hilgart J.S., Coles B., Iredale R. Cancer genetic risk assessment for individuals at risk of familial breast cancer. Cochrane Database Syst Rev 2012, 2:CD003721.
45. A Study of the Communication of Genetic Test Results by Telephone: A Multi-Center Study.
46. Brain K., Norman P., Gray J., et al. A randomized trial of specialist genetic assessment: psychological impact on women at different levels of familial breast cancer risk. Br J Cancer 2002, 86:233-238.
47. Schlich-Bakker K.J., ten Kroode H.F., Ausems M.G. A literature review of the psychological impact of genetic testing on breast cancer patients. Patient Educ Couns 2006, 62:13-20.
48. Halbert C., Kessler L., Collier A., et al. Psychological functioning in African American women at an increased risk of hereditary breast and ovarian cancer. Clin Genet 2005, 68:222-227.
49. Kinney A.Y., Simonsen S.E., Baty B.J., et al. Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American kindred. J Genet Couns 2006, 15:293-305.